Harmony Biosciences (NASDAQ:HRMY) Rating Lowered to Buy at Wall Street Zen
Harmony Biosciences (NASDAQ:HRMY – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday, Wall Street Zen reports. A number of other equities research analysts have also recently weighed in on the company. Zacks Research upgraded Harmony Biosciences from […]
2 Nov 07:34 · The Markets Daily